- Home
- ATOS vs TXMD Comparison
ATOS vs TXMD Comparison
Compare ATOS & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATOS | TXMD |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 22.0M |
| IPO Year | 2010 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ATOS | TXMD |
|---|---|---|
| Price | $2.75 | $1.85 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 93.6K | 19.3K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | $1,758.00 | ★ $1,761,000.00 |
| Revenue This Year | N/A | $207.74 |
| Revenue Next Year | N/A | $2.15 |
| P/E Ratio | ★ N/A | $93.61 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.53 | $1.11 |
| 52 Week High | $7.56 | $2.95 |
Technical Indicators
Market Signals| Indicator | ATOS | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 31.68 |
| Support Level | $2.20 | $1.80 |
| Resistance Level | $3.04 | $2.16 |
| Average True Range (ATR) | 0.27 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 54.00 | 30.33 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.